ArticleCommunications medicine2025

Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma.

David Tougeron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.